Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRaw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tg Therapeutics (TGTX) Total Non-Current Liabilities (2016 - 2025)

Tg Therapeutics (TGTX) has 10 years of Total Non-Current Liabilities data on record, last reported at $413.1 million in Q4 2025.

  • For Q4 2025, Total Non-Current Liabilities rose 17.52% year-over-year to $413.1 million; the TTM value through Dec 2025 reached $413.1 million, up 17.52%, while the annual FY2025 figure was $413.1 million, 17.52% up from the prior year.
  • Total Non-Current Liabilities reached $413.1 million in Q4 2025 per TGTX's latest filing, down from $415.8 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $424.0 million in Q2 2025 and bottomed at $97.5 million in Q3 2021.
  • Average Total Non-Current Liabilities over 5 years is $256.2 million, with a median of $215.5 million recorded in 2024.
  • Peak YoY movement for Total Non-Current Liabilities: decreased 5.19% in 2022, then skyrocketed 108.34% in 2024.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $142.1 million in 2021, then fell by 5.19% to $134.7 million in 2022, then increased by 25.22% to $168.7 million in 2023, then surged by 108.34% to $351.5 million in 2024, then grew by 17.52% to $413.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Total Non-Current Liabilities were $413.1 million in Q4 2025, $415.8 million in Q3 2025, and $424.0 million in Q2 2025.